Journal of Antimicrobial Chemotherapy (2001) 47, 399-403
© 2001 The British Society for Antimicrobial Chemotherapy
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology, North Bristol Health Trust and University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol, BS10 5NB, UK
One hundred methicillin-resistant Staphylococcus aureus (MRSA) strains, isolated between 1983 and 1999, were tested alongside the vancomycin hetero-resistant S. aureus (hVRSA) strain Mu 3, and vancomycin-resistant S. aureus (VRSA) strain Mu 50, for their resistance to vancomycin. This was achieved using the screening method described by Hiramatsu, gradient plates, agar incorporation, standard Etest, macrodilution Etest and a modified population analysis. Using Hiramatsu's screening method, 5% of the 100 MRSA were identified as VRSA and 5% identified as hVRSA, the gradient plates identified 7% hVRSA, and the standard and macrodilution Etests identified no hVRSA. Mu 3 appeared to be vancomycin-susceptible using both the agar incorporation and standard Etest methods, but was classified as hVRSA using the macrodilution Etest. The modified population analysis reliably detected vancomycin hetero-resistance in Mu 3 and identified no hVRSAs within the 100 MRSA sample.
* Corresponding author. Tel: +44-117-959-5654; Fax: +44-117-959-3217; E-mail: mandy_wootton{at}hotmail.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Vidaillac, S. N. Leonard, and M. J. Rybak In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4712 - 4717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Miro, C. Garcia-de-la-Maria, Y. Armero, D. Soy, A. Moreno, A. del Rio, M. Almela, M. Sarasa, C. A. Mestres, J. M. Gatell, et al. Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4172 - 4177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sun, H. Chen, Y. Liu, C. Zhao, W. W. Nichols, M. Chen, J. Zhang, Y. Ma, and H. Wang Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3642 - 3649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Horne, B. P. Howden, E. A. Grabsch, M. Graham, P. B. Ward, S. Xie, B. C. Mayall, P. D. R. Johnson, and M. L. Grayson Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3447 - 3452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Satola, A. M. Caliendo, M. M. Farley, J. B. Patel, and E. M. Burd Lack of Heteroresistance among Staphylococcus aureus Isolates with Vancomycin MICs of 2 Micrograms per Milliliter by Automated Testing J. Clin. Microbiol., August 1, 2009; 47(8): 2680 - 2681. [Full Text] [PDF]
|
|
|
|
|
|
A. Leavitt, I. Chmelnitsky, R. Colodner, I. Ofek, Y. Carmeli, and S. Navon-Venezia Ertapenem Resistance among Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates J. Clin. Microbiol., April 1, 2009; 47(4): 969 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kirby, K. Mohandas, C. Broughton, T. J. Neal, G. W. Smith, P. Pai, and C. Nistal de Paz In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis J. Med. Microbiol., March 1, 2009; 58(3): 376 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Larsen, M. Stegger, S. Bocher, M. Sorum, D. L. Monnet, and R. L. Skov Emergence and Characterization of Community-Associated Methicillin-Resistant Staphyloccocus aureus Infections in Denmark, 1999 to 2006 J. Clin. Microbiol., January 1, 2009; 47(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Howden, T. P. Stinear, D. L. Allen, P. D. R. Johnson, P. B. Ward, and J. K. Davies Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3755 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yusof, A. Engelhardt, A. Karlsson, L. Bylund, P. Vidh, K. Mills, M. Wootton, and T. R. Walsh Evaluation of a New Etest Vancomycin-Teicoplanin Strip for Detection of Glycopeptide-Intermediate Staphylococcus aureus (GISA), in Particular, Heterogeneous GISA J. Clin. Microbiol., September 1, 2008; 46(9): 3042 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lalani, J. J. Federspiel, H. W. Boucher, T. H. Rude, I.-G. Bae, M. J. Rybak, G. T. Tonthat, G. R. Corey, M. E. Stryjewski, G. Sakoulas, et al. Associations between the Genotypes of Staphylococcus aureus Bloodstream Isolates and Clinical Characteristics and Outcomes of Bacteremic Patients J. Clin. Microbiol., September 1, 2008; 46(9): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D'mello, A. J. Daley, M. S. Rahman, Y. Qu, S. Garland, C. Pearce, and M. A. Deighton Vancomycin Heteroresistance in Bloodstream Isolates of Staphylococcus capitis J. Clin. Microbiol., September 1, 2008; 46(9): 3124 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Rybak, S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sadar, and R. N. Jones Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007) J. Clin. Microbiol., September 1, 2008; 46(9): 2950 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Noto, P. M. Fox, and G. L. Archer Spontaneous Deletion of the Methicillin Resistance Determinant, mecA, Partially Compensates for the Fitness Cost Associated with High-Level Vancomycin Resistance in Staphylococcus aureus Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1221 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Chi, T.-L. Lauderdale, S.-M. Wang, J.-M. Wu, Y.-J. Yang, and C.-C. Liu Health Care-Associated Endocarditis Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin J. Clin. Microbiol., February 1, 2008; 46(2): 810 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Amiali, M. R. Mulvey, B. Berger-Bachi, J. Sedman, A. E. Simor, and A. A. Ismail Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus J. Antimicrob. Chemother., January 1, 2008; 61(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Fitzgibbon, A. S. Rossney, and B. O'Connell Investigation of Reduced Susceptibility to Glycopeptides among Methicillin-Resistant Staphylococcus aureus Isolates from Patients in Ireland and Evaluation of Agar Screening Methods for Detection of Heterogeneously Glycopeptide-Intermediate S. aureus J. Clin. Microbiol., October 1, 2007; 45(10): 3263 - 3269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Morand and K. Muhlemann Heteroresistance to penicillin in Streptococcus pneumoniae PNAS, August 28, 2007; 104(35): 14098 - 14103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Fox, M. W. Climo, and G. L. Archer Lack of Relationship between Purine Biosynthesis and Vancomycin Resistance in Staphylococcus aureus: a Cautionary Tale for Microarray Interpretation Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wootton, A. P. MacGowan, T. R. Walsh, and R. A. Howe A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides J. Clin. Microbiol., February 1, 2007; 45(2): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. French Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin J. Antimicrob. Chemother., December 1, 2006; 58(6): 1107 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wootton, A. P. MacGowan, and T. R. Walsh Comparative Bactericidal Activities of Daptomycin and Vancomycin against Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA Isolates Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4195 - 4197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Howden, P. D. R. Johnson, P. B. Ward, T. P. Stinear, and J. K. Davies Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3039 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Renzoni, C. Barras, P. Francois, Y. Charbonnier, E. Huggler, C. Garzoni, W. L. Kelley, P. Majcherczyk, J. Schrenzel, D. P. Lew, et al. Transcriptomic and Functional Analysis of an Autolysis-Deficient, Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3048 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Mariani, H. S. Sader, and R. N. Jones Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy J. Antimicrob. Chemother., August 1, 2006; 58(2): 481 - 483. [Full Text] [PDF]
|
|
|
|
|
|
H. S. Sader, T. R. Fritsche, and R. N. Jones Daptomycin Bactericidal Activity and Correlation between Disk and Broth Microdilution Method Results in Testing of Staphylococcus aureus Strains with Decreased Susceptibility to Vancomycin. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2330 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Garnier, D. Chainier, T. Walsh, A. Karlsson, A. Bolmstrom, C. Grelaud, M. Mounier, F. Denis, and M.-C. Ploy A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital J. Antimicrob. Chemother., January 1, 2006; 57(1): 146 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. J. Brown, D. I. Edwards, P. M. Hawkey, D. Morrison, G. L. Ridgway, K. J. Towner, M. W. D. Wren, and on behalf of the Joint Working Party of the Britis Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA) J. Antimicrob. Chemother., December 1, 2005; 56(6): 1000 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wootton, P. M. Bennett, A. P. MacGowan, and T. R. Walsh Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains J. Antimicrob. Chemother., November 1, 2005; 56(5): 944 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wootton, T. R. Walsh, and A. P. MacGowan Evidence for Reduction in Breakpoints Used To Determine Vancomycin Susceptibility in Staphylococcus aureus Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3982 - 3983. [Full Text] [PDF]
|
|
|
|
|
|
H. S. Sader, T. R. Fritsche, K. Kaniga, Y. Ge, and R. N. Jones Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3501 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. T. Stearne, D. van Boxtel, N. Lemmens, W. H. F. Goessens, J. W. Mouton, and I. C. Gyssens Comparative Study of the Effects of Ceftizoxime, Piperacillin, and Piperacillin-Tazobactam Concentrations on Antibacterial Activity and Selection of Antibiotic-Resistant Mutants of Enterobacter cloacae and Bacteroides fragilis In Vitro and In Vivo in Mixed-Infection Abscesses Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1688 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Verdier, M.-E. Reverdy, J. Etienne, G. Lina, M. Bes, and F. Vandenesch Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides Belong to Accessory Gene Regulator Group I or II Antimicrob. Agents Chemother., March 1, 2004; 48(3): 1024 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wootton, M. B. Avison, P. M. Bennett, R. A. Howe, A. P. MacGowan, and T. R. Walsh Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA J. Antimicrob. Chemother., February 1, 2004; 53(2): 406 - 407. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Howe, M. Wootton, A. R. Noel, K. E. Bowker, T. R. Walsh, and A. P. MacGowan Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3651 - 3652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu and H. F. Chambers Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3040 - 3045. [Full Text] [PDF]
|
|
|
|
|
|
H. B. Kim, W. B. Park, K. D. Lee, Y. J. Choi, S. W. Park, M.-d. Oh, E.-C. Kim, and K. W. Choe Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea J. Clin. Microbiol., June 1, 2003; 41(6): 2279 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Van Griethuysen, A. Van 't Veen, A. Buiting, T. Walsh, and J. Kluytmans High Percentage of Methicillin-Resistant Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides in The Netherlands J. Clin. Microbiol., June 1, 2003; 41(6): 2487 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Decousser, P. Pina, F. Picot, C. Delalande, B. Pangon, P. Courvalin, P. Allouch, and the ColBVH study group Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey J. Antimicrob. Chemother., May 1, 2003; 51(5): 1213 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. MacKenzie, P. Greig, D. Morrison, G. Edwards, and I. M. Gould Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland J. Antimicrob. Chemother., November 1, 2002; 50(5): 689 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-I. Jung, S. Kiem, N. Y. Lee, Y.-S. Kim, W. S. Oh, H. L. Cho, K. R. Peck, and J.-H. Song One-Point Population Analysis and Effect of Osmolarity on Detection of Hetero-Vancomycin-Resistant Staphylococcus aureus J. Clin. Microbiol., April 1, 2002; 40(4): 1493 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Walsh, A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides J. Clin. Microbiol., July 1, 2001; 39(7): 2439 - 2444. [Abstract] [Full Text] [PDF]
|
|